Lena Biosciences, Inc.
Atlanta, GA
- UEI
- HVWSKPM6NUK3
- CAGE
- 555K1
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 6065 Roswell Rd #420, Atlanta, GA 30328, USA
- Website
- lenabio.com
- Founded
- 2008
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| An integrated MPS platform with "virtual humans" for chemical toxicity testing - people are exposed to diverse chemicals… | National Institute of Environmental Health Sciences | $1,961,064 | |
| A microphysiological system with a synthetic hemoglobin, blood substitute, for mechanistic assessment of drug-induced… | National Center for Advancing Translational Sciences | $599,896 | |
| Perfused organ panel as an animal surrogate for chemical toxicity testing - this project responds to the niehs… | National Institute of Environmental Health Sciences | $2,685,002 | |
| Perfused organ panel as an animal surrogate for chemical toxicity testing | National Institute of Environmental Health Sciences | $252,124 | |
| Tools for drug efficacy studies in perfused tissue models | National Institutes of Health | $325,000 |
About Lena Biosciences, Inc.
Lena Biosciences, Inc. is a woman-owned small business and manufacturer of goods specializing in advanced biomedical technologies, with a focus on developing innovative microphysiological screening platforms and cell culture systems. The company is registered in SAM.gov and has been actively receiving federal grants since at least 2020, demonstrating expertise in developing sophisticated in vitro testing models for chemical and pharmaceutical research. Their core technological offerings center on creating advanced 3D cell culture scaffolds and microphysiological systems (MPS) that can simulate human biological responses with high fidelity, enabling more precise and efficient toxicity and drug metabolism testing.
The company has secured multiple significant federal grants from civilian agencies, particularly the National Institute of Environmental Health Sciences (NIEHS) and the National Center for Advancing Translational Sciences (NCATS), focusing on developing cutting-edge screening platforms for chemical toxicity testing. Their projects include developing an integrated microphysiological screening platform with "virtual human" models for assessing chemical toxicity, creating a microphysiological system with synthetic hemoglobin for mechanistic assessment of drug-induced liver injury, and developing a perfused organ panel as an animal surrogate for chemical toxicity testing. These grants, ranging from approximately $900,000 to support specific research initiatives, demonstrate Lena Biosciences' expertise in creating advanced in vitro testing systems that can replicate human cellular responses, assess potential drug and chemical toxicities, and potentially reduce the need for animal testing. The company collaborates with various academic institutions and experts in toxicology, pharmacology, genome biology, and tissue engineering to advance these sophisticated screening technologies.
Quick answers
What is Lena Biosciences, Inc.'s UEI?
Lena Biosciences, Inc.'s Unique Entity ID (UEI) in SAM.gov is HVWSKPM6NUK3.
What is Lena Biosciences, Inc.'s CAGE code?
Lena Biosciences, Inc.'s CAGE code is 555K1.
Where is Lena Biosciences, Inc. located?
Lena Biosciences, Inc.'s physical address in SAM.gov is 6065 Roswell Rd #420, Atlanta, GA 30328, USA.
Is Lena Biosciences, Inc. registered in SAM.gov?
Yes. Lena Biosciences, Inc.'s SAM.gov registration is active through November 25, 2026.
What is Lena Biosciences, Inc.'s most recent federal award?
Lena Biosciences, Inc.'s most recent federal grant award is An integrated MPS platform with "virtual humans" for chemical toxicity testing - people are exposed to diverse chemicals… (R44ES036492), from National Institute of Environmental Health Sciences, on August 22, 2024.
On GovTribe
See Lena Biosciences, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors